➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
McKesson
Mallinckrodt
Moodys
McKinsey

Last Updated: April 22, 2021

DrugPatentWatch Database Preview

Patent Applications for LEVO-T

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Applications for LEVO-T

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Get Started Free   Get Started Free FATTY ACID-PHARMACEUTICAL AGENT CONJUGATES 2000-12-05 Patented Case 2003-05-21
  Get Started Free   Get Started Free Use of sulfamate derivatives for treating impulse control disorders 2000-02-18 Patented Case 2001-11-09
  Get Started Free   Get Started Free PROCESS FOR PRODUCING LIQUID DOSAGE FORMULATIONS OF MEDICINAL COMPOUNDS ON DEMAND FROM TABLETS AND CAPSULES USING A MIXING CUP WITH AN ABRASIVE INTERIOR SURFACE 2001-05-02 Patented Case 2003-04-03
  Get Started Free   Get Started Free Compositions and methods to effect the release profile in the transdermal administration of active agents 2001-01-19 Expressly Abandoned -- During Examination 2002-03-20
  Get Started Free   Get Started Free Retinoid receptor interacting polynucleotides, polypeptides, and antibodies 2001-02-21 Abandoned -- Failure to Respond to an Office Action 2003-02-25
  Get Started Free   Get Started Free Uteroglobin-like polynucleotides, polypeptides, and antibodies 2001-05-02 Abandoned -- Failure to Respond to an Office Action 2004-04-05
  Get Started Free   Get Started Free DHA-PHARMACEUTICAL AGENT CONJUGATES T0 IMPROVE TISSUE SELECTIVITY 2001-05-01 Patented Case 2003-07-17
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

WIPO Patent Applications for LEVO-T

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Johnson and Johnson
Mallinckrodt
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.